Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sambucus nigra flower (elderflower) is the blossom of the European or black elder tree. It has a long history of use in traditional medicine for treating colds, influenza-like illnesses, and other respiratory conditions. The flowers contain antioxidant compounds and may have antidiabetic effects[1][5]. Elderflowers are approved by the German Commission E for use in colds; however, robust clinical evidence supporting their efficacy is limited compared to that for elderberries[5]. The mechanism of action is thought to involve antioxidant activity and possible modulation of inflammatory pathways. Elderflowers are used as dried extracts or infusions in various over-the-counter herbal products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sambucus nigra flower.